Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chia-Yu Chu

Showing results (61-70 of 215) with videos related to

Pageof 22
Sort By:
Journal of Dermatological Science|March 30, 2016
High serum anti-BP180 IgE levels correlate to prominent urticarial lesions in patients with bullous pemphigoidYung-Tsu Cho, Shu-Ling Liao, Li-Fang Wang, et al.
The Journal of Dermatological Treatment|December 4, 2009
Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in TaiwanYi-Shuan Sheen, Chia-Yu Chu, Shiou-Han Wang, et al.
Dermatology and Therapy|June 15, 2023
Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective StudyHao-Chen Hsu, Po-Wei Huang, Yung-Tsu Cho, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 20, 2019
Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapyYung-Tsu Cho, Yu-Ming Huang, Li-Fang Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 15, 2025
Beneficial effect of JAK inhibitor on rapidly progressive acute alopecia areataTyng-Shiuan Hsieh, Po-Hua Chen, Chia-Yu Chu, et al.
Journal of the American Academy of Dermatology|February 28, 2025
Cardiovascular outcomes in patients with bullous pemphigoid on rituximab compared to those on systemic corticosteroids: A propensity-matched retrospective study using the TriNetX databaseRenin Chang, Wen-Hwa Wang, Alisa Chen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 12, 2022
Drug reaction with eosinophilia and systemic symptoms with features resembling Stevens-Johnson syndrome/toxic epidermal necrolysis related to apalutamideYun-Shiuan Olivia Hsu, Tyng-Shiuan Hsieh, Po-Wei Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 18, 2024
Oral propranolol for the treatment of amivantamab-induced scalp ulcers with granulation tissuesPo-Wei Huang, Chong-Jen Yu, James Chih-Hsin Yang, et al.
The Oncologist|April 14, 2018
Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung CancerChia-Yu Chu, Jennifer Choi, Beth Eaby-Sandy, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 22, 2021
Analysis of severe cutaneous adverse reactions (SCARs) in Taiwan drug-injury relief system: 18-year resultsPo-Wei Huang, Mu-Han Chiou, Mei-Yi Chien, et al.
Pageof 22

Showing results (61-70 of 215) with videos related to

Sort By:
Pageof 22
Journal of Dermatological Science|March 30, 2016
High serum anti-BP180 IgE levels correlate to prominent urticarial lesions in patients with bullous pemphigoidYung-Tsu Cho, Shu-Ling Liao, Li-Fang Wang, et al.
The Journal of Dermatological Treatment|December 4, 2009
Dapsone hypersensitivity syndrome in non-leprosy patients: a retrospective study of its incidence in a tertiary referral center in TaiwanYi-Shuan Sheen, Chia-Yu Chu, Shiou-Han Wang, et al.
Dermatology and Therapy|June 15, 2023
Cotrimoxazole as a Preventative Intervention for Pneumocystis Pneumonia in Pemphigus Patients Treated with Rituximab: A Retrospective StudyHao-Chen Hsu, Po-Wei Huang, Yung-Tsu Cho, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 20, 2019
Maintenance therapy with azathioprine prolonged duration of remission for pemphigus patients who received rituximab as first-line or add-on therapyYung-Tsu Cho, Yu-Ming Huang, Li-Fang Wang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 15, 2025
Beneficial effect of JAK inhibitor on rapidly progressive acute alopecia areataTyng-Shiuan Hsieh, Po-Hua Chen, Chia-Yu Chu, et al.
Journal of the American Academy of Dermatology|February 28, 2025
Cardiovascular outcomes in patients with bullous pemphigoid on rituximab compared to those on systemic corticosteroids: A propensity-matched retrospective study using the TriNetX databaseRenin Chang, Wen-Hwa Wang, Alisa Chen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 12, 2022
Drug reaction with eosinophilia and systemic symptoms with features resembling Stevens-Johnson syndrome/toxic epidermal necrolysis related to apalutamideYun-Shiuan Olivia Hsu, Tyng-Shiuan Hsieh, Po-Wei Huang, et al.
Lung Cancer (Amsterdam, Netherlands)|November 18, 2024
Oral propranolol for the treatment of amivantamab-induced scalp ulcers with granulation tissuesPo-Wei Huang, Chong-Jen Yu, James Chih-Hsin Yang, et al.
The Oncologist|April 14, 2018
Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung CancerChia-Yu Chu, Jennifer Choi, Beth Eaby-Sandy, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 22, 2021
Analysis of severe cutaneous adverse reactions (SCARs) in Taiwan drug-injury relief system: 18-year resultsPo-Wei Huang, Mu-Han Chiou, Mei-Yi Chien, et al.
Pageof 22